ミズホメディーの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/04/09 | 3,380 | 3,400 | 3,360 | 3,400 | +25 | +0.7% | 45,800 |
2024/04/08 | 3,360 | 3,390 | 3,340 | 3,375 | +25 | +0.7% | 44,400 |
2024/04/05 | 3,325 | 3,350 | 3,305 | 3,350 | +20 | +0.6% | 28,200 |
2024/04/04 | 3,340 | 3,350 | 3,310 | 3,330 | -10 | -0.3% | 51,100 |
2024/04/03 | 3,310 | 3,370 | 3,305 | 3,340 | +45 | +1.4% | 47,100 |
2024/04/02 | 3,345 | 3,345 | 3,290 | 3,295 | -50 | -1.5% | 44,700 |
2024/04/01 | 3,365 | 3,370 | 3,325 | 3,345 | -20 | -0.6% | 60,100 |
2024/03/29 | 3,275 | 3,365 | 3,270 | 3,365 | +110 | +3.4% | 78,600 |
2024/03/28 | 3,235 | 3,280 | 3,230 | 3,255 | +20 | +0.6% | 28,600 |
2024/03/27 | 3,235 | 3,305 | 3,235 | 3,235 | +15 | +0.5% | 75,800 |
2024/03/26 | 3,235 | 3,235 | 3,195 | 3,220 | -10 | -0.3% | 57,700 |
2024/03/25 | 3,250 | 3,270 | 3,230 | 3,230 | -20 | -0.6% | 37,100 |
2024/03/22 | 3,245 | 3,270 | 3,205 | 3,250 | +20 | +0.6% | 74,300 |
2024/03/21 | 3,270 | 3,270 | 3,225 | 3,230 | -45 | -1.4% | 83,500 |
2024/03/19 | 3,275 | 3,275 | 3,245 | 3,275 | ±0 | ±0% | 30,700 |
2024/03/18 | 3,270 | 3,280 | 3,255 | 3,275 | +15 | +0.5% | 35,200 |
2024/03/15 | 3,285 | 3,290 | 3,225 | 3,260 | -30 | -0.9% | 82,900 |
2024/03/14 | 3,285 | 3,310 | 3,260 | 3,290 | +30 | +0.9% | 37,700 |
2024/03/13 | 3,325 | 3,330 | 3,245 | 3,260 | -60 | -1.8% | 40,400 |
2024/03/12 | 3,265 | 3,320 | 3,250 | 3,320 | +50 | +1.5% | 43,700 |
2024/03/11 | 3,295 | 3,300 | 3,250 | 3,270 | -25 | -0.8% | 31,000 |
2024/03/08 | 3,245 | 3,325 | 3,245 | 3,295 | +45 | +1.4% | 55,700 |
2024/03/07 | 3,285 | 3,300 | 3,250 | 3,250 | -30 | -0.9% | 40,000 |
2024/03/06 | 3,280 | 3,305 | 3,275 | 3,280 | -10 | -0.3% | 40,400 |
2024/03/05 | 3,345 | 3,365 | 3,280 | 3,290 | -55 | -1.6% | 51,700 |
2024/03/04 | 3,340 | 3,375 | 3,325 | 3,345 | +5 | +0.1% | 46,300 |
2024/03/01 | 3,355 | 3,385 | 3,330 | 3,340 | +10 | +0.3% | 47,500 |
2024/02/29 | 3,300 | 3,345 | 3,255 | 3,330 | +25 | +0.8% | 52,400 |
2024/02/28 | 3,255 | 3,330 | 3,255 | 3,305 | +65 | +2% | 64,700 |
2024/02/27 | 3,320 | 3,320 | 3,240 | 3,240 | -105 | -3.1% | 142,100 |
2024/02/26 | 3,355 | 3,375 | 3,325 | 3,345 | ±0 | ±0% | 48,600 |
2024/02/22 | 3,375 | 3,385 | 3,335 | 3,345 | -30 | -0.9% | 58,000 |
2024/02/21 | 3,400 | 3,405 | 3,360 | 3,375 | -30 | -0.9% | 37,100 |
2024/02/20 | 3,450 | 3,470 | 3,385 | 3,405 | -40 | -1.2% | 58,100 |
2024/02/19 | 3,380 | 3,450 | 3,380 | 3,445 | +70 | +2.1% | 46,100 |
2024/02/16 | 3,370 | 3,420 | 3,340 | 3,375 | +30 | +0.9% | 80,400 |
2024/02/15 | 3,400 | 3,430 | 3,315 | 3,345 | -105 | -3% | 163,000 |
2024/02/14 | 3,565 | 3,620 | 3,435 | 3,450 | -130 | -3.6% | 171,400 |
2024/02/13 | 3,645 | 3,750 | 3,475 | 3,580 | -235 | -6.2% | 393,100 |
2024/02/09 | 3,390 | 3,820 | 3,355 | 3,815 | +390 | +11.4% | 942,500 |
2024/02/08 | 3,395 | 3,445 | 3,345 | 3,425 | +70 | +2.1% | 165,100 |
2024/02/07 | 3,375 | 3,380 | 3,325 | 3,355 | -20 | -0.6% | 116,300 |
2024/02/06 | 3,395 | 3,405 | 3,375 | 3,375 | -25 | -0.7% | 97,000 |
2024/02/05 | 3,455 | 3,460 | 3,370 | 3,400 | -55 | -1.6% | 145,400 |
2024/02/02 | 3,480 | 3,485 | 3,440 | 3,455 | -5 | -0.1% | 60,100 |
2024/02/01 | 3,500 | 3,500 | 3,435 | 3,460 | -40 | -1.1% | 80,700 |
2024/01/31 | 3,510 | 3,515 | 3,455 | 3,500 | -10 | -0.3% | 82,700 |
2024/01/30 | 3,520 | 3,570 | 3,510 | 3,510 | ±0 | ±0% | 80,200 |
2024/01/29 | 3,485 | 3,520 | 3,480 | 3,510 | +45 | +1.3% | 66,900 |
2024/01/26 | 3,500 | 3,500 | 3,455 | 3,465 | -30 | -0.9% | 84,500 |
251~
300
件表示中 / 2279件
類似銘柄と比較する
現在ご覧いただいている「ミズホメディ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ミズホメディ | 146,300円 | +1.2% | -13.9% | 5.81% | 8.63倍 | 1.61倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
ダイト | 201,000円 | +4.5% | -33.7% | 3.48% | 20.25倍 | 0.58倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック(後発医薬品)メーカー向け強い |
ヘリオス | 27,800円 | +150.0% | - | 0.00% | - | 13.65倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
扶桑薬 | 224,200円 | +8.3% | +98.1% | 3.66% | 7.37倍 | 0.51倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
アンジェス | 6,300円 | +110.0% | - | 0.00% | - | 10.05倍 |
|
大阪大医学部、森下竜一教授創業の創薬ベンチャー。遺伝子治療薬を核に核酸医薬など開発多彩 |
市場注目の銘柄
チャート関連のコラム